Schonfeld Strategic Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-42,575
| Closed | -$1.74M | – | 2355 |
|
|
2024
Q2 | $1.74M | Buy |
42,575
+40,905
| +2,449% | +$1.67M | 0.01% | 849 |
|
|
2024
Q1 | $70.6K | Buy |
1,670
+1,153
| +223% | +$48.7K | ﹤0.01% | 1689 |
|
|
2023
Q4 | $21.9K | Buy |
+517
| New | +$21.9K | ﹤0.01% | 1608 |
|
|
2023
Q3 | – | Sell |
-66,390
| Closed | -$2.11M | – | 2220 |
|
|
2023
Q2 | $2.11M | Buy |
+66,390
| New | +$2.11M | 0.02% | 733 |
|
|
2023
Q1 | – | Sell |
-15,400
| Closed | -$486K | – | 2673 |
|
|
2022
Q4 | $486K | Buy |
+15,400
| New | +$486K | ﹤0.01% | 1523 |
|
|
2022
Q1 | – | Sell |
-8,546
| Closed | -$277K | – | 2801 |
|
|
2021
Q4 | $277K | Buy |
+8,546
| New | +$277K | ﹤0.01% | 1478 |
|
|
2021
Q2 | – | Sell |
-13,002
| Closed | -$178K | – | 2338 |
|
|
2021
Q1 | $178K | Buy |
+13,002
| New | +$178K | ﹤0.01% | 1507 |
|